{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anticancer", "Colon cancer", "Eclipta alba", "Nontoxic", "Normal cells", "Specificity"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "33225921", "DateCompleted": {"Year": "2021", "Month": "07", "Day": "20"}, "DateRevised": {"Year": "2021", "Month": "07", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "11", "Day": "23"}], "Language": ["eng"], "ELocationID": ["355", "10.1186/s12906-020-03118-9"], "Journal": {"ISSN": "2662-7671", "JournalIssue": {"Volume": "20", "Issue": "1", "PubDate": {"Year": "2020", "Month": "Nov", "Day": "23"}}, "Title": "BMC complementary medicine and therapies", "ISOAbbreviation": "BMC Complement Med Ther"}, "ArticleTitle": "In vitro anticancer activity of Eclipta alba whole plant extract on colon cancer cell HCT-116.", "Pagination": {"StartPage": "355", "MedlinePgn": "355"}, "Abstract": {"AbstractText": ["Colon cancer is the third most deadly and one of the most diagnosed diseases in the world. Although routine screening and early detection during last decades has improved the survival, colon cancer still claims hundreds of thousands lives each year worldwide. Surgery and chemotherapy is mainstay of current treatment, nevertheless toxicity associated with this treatment underscores the urgency of demand of a better therapeutics. Close to 50% of current chemotherapeutic drugs are direct or indirect descendants compounds isolated from medicinal plants, which indicate plants are great potential sources of novel therapeutics. In our literature review we found Eclipta alba to posses many pharmacological activities, including those with anticancer potentials. However, no study on anticancer activity of this kind has been reported.", "Phytochemicals were extracted by maceration method from shade dried whole plant of Eclipta alba using methanol as a solvent. The anticancer effect of extract was investigated on various cancer cell lines like human colorectal carcinoma (HCT-116), human prostate cancer (PC-3), Michigan cancer foundation-breast cancer (MCF-7) and renal cell carcinoma (RCC-45). We have also studied the effects on normal human embryonic lung fibroblast cell (WI-38) using MTT (methyl thiazoldiphenyltetrazolium bromide) assay, clonogenic (colony formation) and migration assay. Finally obtained results were analyzed using ANNOVA and Dunnett's test.", "Results obtained from MTT assay revealed that the methanolic extract of Eclipta alba carried significant (p\u2009<\u20090.005) specificity against HCT-116 cells as compared to the other cancer cells. This extract also showed minimal or nontoxicity to WI-38 cells. Migration as well as clonogenic assays also confirmed the anticancer potential of the extract against HCT-116 cells.", "This is a unique finding of its kind because the specific anticancer effect with minimal toxicity on normal cells has not been reported on Eclipta alba extract. Finally this finding opens up a great possibility to develop a novel antitumor drug candidate against deadly colon cancer in the future."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Raghavendra Institute of Pharmaceutical Education & Research (Autonomous), Anantapuramu, Andhra Pradesh, 515721, India. sahoomlrip@gmail.com."}], "LastName": "Nelson", "ForeName": "Vinod Kumar", "Initials": "VK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Marri Laxman Reddy Institute of Pharmacy, Medchal, Dundigal, Telangana, 500043, India."}], "LastName": "Sahoo", "ForeName": "Nalini Kanta", "Initials": "NK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Marri Laxman Reddy Institute of Pharmacy, Medchal, Dundigal, Telangana, 500043, India."}], "LastName": "Sahu", "ForeName": "Madhusmita", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Raghavendra Institute of Pharmaceutical Education & Research (Autonomous), Anantapuramu, Andhra Pradesh, 515721, India."}], "LastName": "Sudhan", "ForeName": "Hari Hara", "Initials": "HH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Siddha Central Research Institute, Chennai, Tamil Nadu, 60016, India."}], "LastName": "Pullaiah", "ForeName": "Chitikela P", "Initials": "CP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Marri Laxman Reddy Institute of Pharmacy, Medchal, Dundigal, Telangana, 500043, India."}], "LastName": "Muralikrishna", "ForeName": "Kanuri Sai", "Initials": "KS"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Med Ther", "NlmUniqueID": "101761232", "ISSNLinking": "2662-7671"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Movement"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Colonic Neoplasms"}, {"QualifierName": [], "DescriptorName": "Eclipta"}, {"QualifierName": [], "DescriptorName": "HCT116 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "India"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Zhang Z, Zhou L, Xie N, Nice EC, Zhang T, Cui Y, Huang C. Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduct Target Ther. 2020;5:113. doi: 10.1038/s41392-020-00213-8.", "ArticleIdList": ["10.1038/s41392-020-00213-8", "PMC7331117", "32616710"]}, {"Citation": "Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. doi: 10.3322/caac.21492.", "ArticleIdList": ["10.3322/caac.21492", "30207593"]}, {"Citation": "Yadav NK, Arya RK, Dev K, Sharma C, Hossain Z, Meena S, Arya KR, Gayen JR, Datta D, Singh RK. Alcoholic Extract of Eclipta alba Shows In Vitro Antioxidant and Anticancer Activity without Exhibiting Toxicological Effects. Oxidative Med Cell Longev. 2017;2017:9094641. doi: 10.1155/2017/9094641.", "ArticleIdList": ["10.1155/2017/9094641", "PMC5307245", "28250894"]}, {"Citation": "Gothai S, Muniandy K, Mohd Esa N, Subbiah S, Arulselvan P. Anticancer potential of Alternanthera sessilis extract on HT-29 human colon cancer cells. Asian Pac J Trop Biomed. 2018;8:394\u2013402. doi: 10.4103/2221-1691.239427.", "ArticleIdList": ["10.4103/2221-1691.239427"]}, {"Citation": "Wiman KG, Zhivotovsky B. Understanding cell cycle and cell death regulation provides novel weapons against human diseases. J Intern Med. 2017;281:483\u2013495. doi: 10.1111/joim.12609.", "ArticleIdList": ["10.1111/joim.12609", "28374555"]}, {"Citation": "Matsuoka T, Yashiro M. Biomarkers of gastric cancer. Current topics and future perspective. World J Gastroenterol. 2018;24:2818\u20132832. doi: 10.3748/wjg.v24.i26.2818.", "ArticleIdList": ["10.3748/wjg.v24.i26.2818", "PMC6048430", "30018477"]}, {"Citation": "Imran A, Qamar HY, Ali Q, Naeem H, Riaz M, Amin S, Kanwal N, Ali F, Sabar MF, Nasir IA. Role of Molecular Biology in Cancer Treatment: A Review Article. Iran J Public Health. 2017;46:1475\u20131485.", "ArticleIdList": ["PMC5696686", "29167765"]}, {"Citation": "Xie YH, Chen YX, Fang JY. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther. 2020;5:22. doi: 10.1038/s41392-020-0116-z.", "ArticleIdList": ["10.1038/s41392-020-0116-z", "PMC7082344", "32296018"]}, {"Citation": "Zaman A, Khan MS, Akter L, Syeed SH, Akter J, Al Mamun A, Alam ME, Habib MA, Jalil MA. Exploring new pharmacology and toxicological screening and safety evaluation of one widely used formulation of Nidrakar Bati from South Asia region. BMC Complement Altern Med. 2015;15:121. doi: 10.1186/s12906-015-0635-2.", "ArticleIdList": ["10.1186/s12906-015-0635-2", "PMC4415343", "25880852"]}, {"Citation": "Tambe R, Patil A, Jain P, Sancheti J, Somani G, Sathaye S. Assessment of luteolin isolated from Eclipta alba leaves in animal models of epilepsy. Pharm Biol. 2017;55:264\u2013268. doi: 10.1080/13880209.2016.1260597.", "ArticleIdList": ["10.1080/13880209.2016.1260597", "PMC6130635", "27927066"]}, {"Citation": "Gupta R, Sharma AK, Dobhal MP, Sharma MC, Gupta RS. Antidiabetic and antioxidant potential of \u03b2-sitosterol in streptozotocin-induced experimental hyperglycemia. J Diabetes. 2011;3:29\u201337. doi: 10.1111/j.1753-0407.2010.00107.x.", "ArticleIdList": ["10.1111/j.1753-0407.2010.00107.x", "21143769"]}, {"Citation": "Couder-Garc\u00eda BDC, Jacobo-Herrera NJ, Zentella-Dehesa A, Rocha-Zavaleta L, Tavarez-Santamar\u00eda Z, Mart\u00ednez-V\u00e1zquez M. The Phytosterol Peniocerol Inhibits Cell Proliferation and Tumor Growth in a Colon Cancer Xenograft Model. Front Oncol. 2019;9:1341. doi: 10.3389/fonc.2019.01341.", "ArticleIdList": ["10.3389/fonc.2019.01341", "PMC6901603", "31850224"]}, {"Citation": "Jahan R, Al-Nahain A, Majumder S, Rahmatullah M. Ethnopharmacological Significance of Eclipta alba (L.) Hassk. (Asteraceae) Int Sch Res Notices. 2014;2014:385969.", "ArticleIdList": ["PMC4897414", "27355071"]}, {"Citation": "Lombardi VR, Carrera I, Cacabelos R. In Vitro Screening for Cytotoxic Activity of Herbal Extracts. Evid Based Complement Alternat Med. 2017;2017:2675631. doi: 10.1155/2017/2675631.", "ArticleIdList": ["10.1155/2017/2675631", "PMC5366791", "28386288"]}, {"Citation": "Mosmann T. Rapid colorimetric assay for cellular growth and survival. application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55\u201363. doi: 10.1016/0022-1759(83)90303-4.", "ArticleIdList": ["10.1016/0022-1759(83)90303-4", "6606682"]}, {"Citation": "Nelson VK, Ali A, Dutta N, Ghosh S, Jana M, Ganguli A, Komarov A, Paul S, Dwivedi V, Chatterjee S, et al. Azadiradione ameliorates polyglutamine expansion disease in Drosophila by potentiating DNA binding activity of heat shock factor 1. Oncotarget. 2016;7:78281\u201378296. doi: 10.18632/oncotarget.12930.", "ArticleIdList": ["10.18632/oncotarget.12930", "PMC5346638", "27835876"]}, {"Citation": "Banerjee A, Ahmed H, Yang P, Czinn SJ, Blanchard TG. Endoplasmic reticulum stress and IRE-1 signaling cause apoptosis in colon cancer cells in response to andrographolide treatment. Oncotarget. 2016;7:41432\u201341444. doi: 10.18632/oncotarget.9180.", "ArticleIdList": ["10.18632/oncotarget.9180", "PMC5173070", "27166181"]}, {"Citation": "Bolla SR, Mohammed Al-Subaie A, Yousuf Al-Jindan R, Papayya Balakrishna J, Kanchi Ravi P, Veeraraghavan VP, Arumugam Pillai A, Gollapalli SSR, Palpath Joseph J, Surapaneni KM. In vitro wound healing potency of methanolic leaf extract of Aristolochia saccata is possibly mediated by its stimulatory effect on collagen-1 expression. Heliyon. 2019;5:e01648. doi: 10.1016/j.heliyon.2019.e01648.", "ArticleIdList": ["10.1016/j.heliyon.2019.e01648", "PMC6529694", "31193473"]}, {"Citation": "Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg. 2009;22:191\u2013197. doi: 10.1055/s-0029-1242458.", "ArticleIdList": ["10.1055/s-0029-1242458", "PMC2796096", "21037809"]}, {"Citation": "Anand P, Kunnumakkara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, Sung B, Aggarwal BB. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res. 2008;25:2097\u20132116. doi: 10.1007/s11095-008-9661-9.", "ArticleIdList": ["10.1007/s11095-008-9661-9", "PMC2515569", "18626751"]}, {"Citation": "Ogbole OO, Segun PA, Adeniji AJ. In vitro cytotoxic activity of medicinal plants from Nigeria ethnomedicine on Rhabdomyosarcoma cancer cell line and HPLC analysis of active extracts. BMC Complement Altern Med. 2017;17:494. doi: 10.1186/s12906-017-2005-8.", "ArticleIdList": ["10.1186/s12906-017-2005-8", "PMC5700537", "29166892"]}, {"Citation": "Liou GY, Storz P. Reactive oxygen species in cancer. Free Radic Res. 2010;44:479\u2013496. doi: 10.3109/10715761003667554.", "ArticleIdList": ["10.3109/10715761003667554", "PMC3880197", "20370557"]}, {"Citation": "Qian Q, Chen W, Cao Y, Cao Q, Cui Y, Li Y, Wu J. Targeting Reactive Oxygen Species in Cancer via Chinese Herbal Medicine. Oxidative Med Cell Longev. 2019;2019:9240426.", "ArticleIdList": ["PMC6754955", "31583051"]}, {"Citation": "Snezhkina AV, Kudryavtseva AV, Kardymon OL, Savvateeva MV, Melnikova NV, Krasnov GS, Dmitriev AA. ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells. Oxidative Med Cell Longev. 2019;2019:6175804. doi: 10.1155/2019/6175804.", "ArticleIdList": ["10.1155/2019/6175804", "PMC6701375", "31467634"]}, {"Citation": "Baskar AA, Ignacimuthu S, Paulraj GM, Al Numair KS. Chemopreventive potential of beta-Sitosterol in experimental colon cancer model--an in vitro and In vivo study. BMC Complement Altern Med. 2010;10:24. doi: 10.1186/1472-6882-10-24.", "ArticleIdList": ["10.1186/1472-6882-10-24", "PMC2887773", "20525330"]}, {"Citation": "Bignell GR, Greenman CD, Davies H, Butler AP, Edkins S, Andrews JM, Buck G, Chen L, Beare D, Latimer C, et al. Signatures of mutation and selection in the cancer genome. Nature. 2010;463:893\u2013898. doi: 10.1038/nature08768.", "ArticleIdList": ["10.1038/nature08768", "PMC3145113", "20164919"]}, {"Citation": "Armaghany T, Wilson JD, Chu Q, Mills G. Genetic alterations in colorectal cancer. Gastrointest Cancer Res. 2012;5:19\u201327.", "ArticleIdList": ["PMC3348713", "22574233"]}, {"Citation": "Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. JAMA. 2017;317:2402\u20132416. doi: 10.1001/jama.2017.7112.", "ArticleIdList": ["10.1001/jama.2017.7112", "28632866"]}, {"Citation": "Khan MSS, Salam MA, Haque RSMA, Abdul Majid AMS, Abdul Majid ASB, Asif M, Basheer MKA, Tabana YM, Hsu TC. Synthesis, cytotoxicity, and long-term single dose anti-cancer pharmacological evaluation of dimethyltin(IV) complex of N(4)-methylthiosemicarbazone (having ONS donor ligand) Cogent Biol. 2016;2(1):1\u201325."}]}], "History": [{"Year": "2020", "Month": "5", "Day": "8"}, {"Year": "2020", "Month": "10", "Day": "18"}, {"Year": "2020", "Month": "11", "Day": "23", "Hour": "8", "Minute": "42"}, {"Year": "2020", "Month": "11", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["33225921", "PMC7681951", "10.1186/s12906-020-03118-9", "10.1186/s12906-020-03118-9"]}}]}